OrthoCor Advanced System for Osteoarthritis

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Caerus Corporation

Disqualifiers: Rheumatoid arthritis, Gout, Heart disease, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

Duration: 4 weeks

30 Participants Needed

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.

What is the purpose of this trial?

The objective of this clinical trial is to show that PEMF therapy, heat, recovery metrics, and compliance data provided by the OrthoCor Advanced System improves pain and quality of life for patients with osteoarthritis. The main question it aims to answer is: Does therapy from the OrthoCor Advanced System improve symptoms of osteoarthritis? Researchers will compare range of motion measurements, sit to stand test results, and functional survey answers to see if there are any changes after 4 weeks of therapy with the OrthoCor Advanced System. Participants will use the OrthoCor Active System for 30 minutes twice daily and complete recovery measurements daily using an application.

Research Team

Joshua G Hackel, MD

Principal Investigator

The Andrews Research & Education Foundation

Eligibility Criteria

This trial is for individuals with osteoarthritis who are seeking to improve their pain and quality of life. Participants will be required to use the OrthoCor Advanced System twice daily and track recovery metrics using an app.

Inclusion Criteria

Willing and able to provide written consent

Prescribed use of the OrthoCor Advanced System

Daily access to a smartphone or tablet compatible with the OrthoCor Medical application

Exclusion Criteria

Unwilling or unable to provide written consent

Unwilling or unable to use the OrthoCor Advanced System

I have not had a cortisone injection, knee surgery, or viscosupplementation in the last 6 months.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants use the OrthoCor Advanced System for 30 minutes twice daily for 4 weeks, with daily recovery measurements and monitoring of mobility metrics

4 weeks

Daily use with remote monitoring

Follow-up

Participants are monitored for safety and effectiveness after treatment, including assessments of range of motion and pain levels

4 weeks

Treatment Details

Interventions

• OrthoCor Advanced System

Trial Overview The trial tests if PEMF therapy combined with heat from the OrthoCor Advanced System can relieve symptoms of osteoarthritis. It measures changes in range of motion, sit-to-stand test results, and survey responses after 4 weeks.

Participant Groups

Group I: OrthoCor Advanced System Experimental Treatment 1 Intervention

The OrthoCor Advanced System's novel combination of PEMF with the ability to monitor mobility metrics may have additional beneficial effects on pain, function, and quality of life for individuals affected by osteoarthritis.

Who Is Running the Clinical Trial?

Caerus Corporation

Lead Sponsor

Trials

2

Recruited

150+